Compare Stocks → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:AFIBNASDAQ:AMDANASDAQ:MOTSNASDAQ:OSAP Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.04$0.13$0.04▼$0.99$1.32M0.251.11 million shs73,393 shsAMDAAmedica$7.25-6.1%$0.26$0.18▼$6.40$86.06M-1.241.07 million shs119,990 shsMOTSMotus GI$0.18+12.5%$0.20$0.05▼$14.25$905K1.5126,772 shs115,454 shsOSAPProSomnus$0.03+42.6%$0.00$0.02▼$5.10$583K0.677,237 shs780 shsBeginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical-7.52%-2.63%-71.02%-78.88%-94.78%AMDAAmedica-6.09%+10,624.85%+15,424.63%+5,104.59%+393.20%MOTSMotus GI0.00%+30.43%+150.00%-73.51%-98.24%OSAPProSomnus+19.64%+19.22%-66.83%+3,349,900.00%+3,349,900.00%This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFIBAcutus MedicalN/AN/AN/AN/AN/AN/AN/AN/AAMDAAmedicaN/AN/AN/AN/AN/AN/AN/AN/AMOTSMotus GIN/AN/AN/AN/AN/AN/AN/AN/AOSAPProSomnusN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus MedicalN/AN/AN/AN/AAMDAAmedicaN/AN/AN/AN/AMOTSMotus GI3.00Buy$28.8815,941.67% UpsideOSAPProSomnusN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.18N/AN/A($0.14) per share-0.32AMDAAmedica$11.23M7.66N/AN/A$1.80 per share4.03MOTSMotus GI$320K2.83N/AN/A$0.61 per share0.30OSAPProSomnus$27.65M0.02N/AN/A($2.33) per share-0.01Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66MN/A0.00∞N/A-166.79%-54.97%-13.82%N/AAMDAAmedica-$9.32M-$3.13N/AN/AN/A-139.62%-148.60%-67.83%N/AMOTSMotus GI-$12.87M-$15.64N/A∞N/A-3,239.75%-1,731.08%-115.99%N/AOSAPProSomnus-$24.09M-$1.56N/A∞N/A-87.14%N/A-106.30%N/ALatest AMDA, OSAP, MOTS, and AFIB EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2024Q1 2024MOTSMotus GIN/A-$0.88-$0.88-$0.88N/A$0.06 million5/9/2024Q1 2024AFIBAcutus MedicalN/A-$0.07-$0.07-$0.08N/A$3.63 million3/27/2024Q4 2023OSAPProSomnusN/A-$0.42-$0.42-$0.42N/A$7.84 million3/18/2024Q4 2023MOTSMotus GIN/A-$4.13-$4.13-$3.78N/A$0.06 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/AAMDAAmedicaN/AN/AN/AN/AN/AMOTSMotus GIN/AN/AN/AN/AN/AOSAPProSomnusN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus Medical1.103.482.89AMDAAmedicaN/A1.110.99MOTSMotus GI0.221.741.67OSAPProSomnusN/A1.000.86OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%AMDAAmedica3.72%MOTSMotus GI20.06%OSAPProSomnus70.03%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical5.21%AMDAAmedica0.90%MOTSMotus GI1.57%OSAPProSomnus7.70%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical23029.72 million28.17 millionOptionableAMDAAmedicaN/A11.87 millionN/ANot OptionableMOTSMotus GI155.03 million4.95 millionNot OptionableOSAPProSomnus13617.39 million16.06 millionN/AAMDA, OSAP, MOTS, and AFIB HeadlinesRecent News About These CompaniesMay 30 at 6:00 AM | globenewswire.comProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research SocietyMay 16, 2024 | globenewswire.comProSomnus Announces Strong First Quarter 2024 Revenue GrowthMay 13, 2024 | globenewswire.comProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual MeetingNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsAcutus MedicalNASDAQ:AFIBAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.AmedicaNASDAQ:AMDASINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.Motus GINASDAQ:MOTSMotus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.ProSomnusNASDAQ:OSAPProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
